![Alexis Peyroles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexis Peyroles
Plus aucun poste en cours
Fortune : 2 M $ au 31/05/2026
Profil
Alexis Peyroles is the founder of Inside Therapeutics SAS, serving as Chairman & Chief Financial Officer since 2022.
Current jobs include Chief Executive Officer at Ose Immunotherapeutics, Inc., Chief Executive Officer & Director at Betaglue Technologies SpA starting in 2025, and Chairman at Aperana Consulting SAS. Former jobs include Chief Executive Officer & Director at OSE Immunotherapeutics SA from 2018 to 2022, Chief Executive Officer at Guerbet Imagem do Brasil Ltda., Manager-Financial Control at Guerbet SA, Head-Financial Control-Baltic States at Sanofi-Aventis Japan, Head-Eastern Europe Business Development at Sanofi-Aventis France SA, and CFO & Head-Business Development at Orphan Synergy Europe-Pharma SA. Education includes an undergraduate degree from École des Hautes Études Commerciales du Nord and an MBA from Imperial College Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2025 | 293 848 ( 1,3 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Alexis Peyroles
| Sociétés | Poste | Début |
|---|---|---|
Aperana Consulting SAS | Président | - |
Ose Immunotherapeutics, Inc. | Directeur Général | - |
Betaglue Technologies SpA
 Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Directeur Général | 22/09/2025 |
Anciens postes connus de Alexis Peyroles
| Sociétés | Poste | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur Général | 16/01/2022 |
Guerbet Imagem do Brasil Ltda. | Directeur Général | - |
Sanofi-Aventis Japan | Comptroller/Controller/Auditor | - |
| GUERBET | Comptroller/Controller/Auditor | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Formation de Alexis Peyroles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Guerbet SA
 Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products | Health Technology |
Sanofi-Aventis Japan | |
École des Hautes Études Commerciales du Nord
 École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Imperial College Business School
 Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aperana Consulting SAS | |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Commercial Services |
Ose Immunotherapeutics, Inc. | |
Guerbet Imagem do Brasil Ltda. |
